Study of FOXO3a and the development of tamoxifen resistance in breast cancer

被引：0
|
作者：
Chen, Jie
Wu, Lai-han
Ip, Ying-Chi
Chan, Kelvin Y. K.
Lam, Eric W-F
Khoo, Ui-soon
机构：
[1] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
[2] Univ London Imperial Coll Sci Technol & Med, Dept Oncol, Canc Res UK Labs, London, England
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4724
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The role of mitochondrial/metabolic axis in development of tamoxifen resistance in breast cancer
    Hany N. Azzam
    Marwa O. El-Derany
    Sara A. Wahdan
    Reham M. Faheim
    Gouda K. Helal
    Ebtehal El-Demerdash
    Human Cell, 2023, 36 : 1877 - 1886
  • [42] Breast cancer suppression by aplysin is associated with inhibition of PI3K/AKT/FOXO3a pathway
    Zhang, Xinling
    Zhuang, Tingting
    Liang, Zhengyan
    Li, Li
    Xue, Meilan
    Liu, Jia
    Liang, Hui
    ONCOTARGET, 2017, 8 (38) : 63923 - 63934
  • [43] FOXO3a expression in colorectal cancer: A promising biomarker of micrometastases
    Bruce, A.
    Bullock, M.
    Curtis, N.
    Sreekumar, R.
    Primrose, J.
    Thomas, G.
    Mirnezami, A. H.
    BRITISH JOURNAL OF SURGERY, 2013, 100 : 7 - 7
  • [44] Natural bioactive compounds and FOXO3a in cancer therapeutics: An update
    Manoharan, Suryaa
    Prajapati, Kunjkumar
    Perumal, Ekambaram
    FITOTERAPIA, 2024, 173
  • [45] Pro-carcinogenic actions of miR-155/FOXO3a in colorectal cancer development
    Wang, Dianxiu
    Geng, Wei
    Han, Lu
    Song, Ran
    Qu, Qiusi
    Chen, Xingyuan
    Luo, Xi
    CELLULAR AND MOLECULAR BIOLOGY, 2023, 69 (10) : 160 - 165
  • [46] FOXO3a Genotype Predicts Age of Breast Cancer Onset and Correlates with Lymph Node Involvement.
    Brouwers, B.
    Lambrechts, D.
    Hatse, S.
    Dieudonne, A-S
    Remmerie, C.
    Neven, P.
    Smeets, A.
    Paridaens, R.
    Wildiers, H.
    CANCER RESEARCH, 2011, 71
  • [47] Constitutively Nuclear FOXO3a Localization Predicts Poor Survival and Promotes Akt Phosphorylation in Breast Cancer
    Chen, Jie
    Gomes, Ana R.
    Monteiro, Lara J.
    Wong, San Yu
    Wu, Lai Han
    Ng, Ting-Ting
    Karadedou, Christina T.
    Millour, Julie
    Ip, Ying-Chi
    Cheung, Yuen Nei
    Sunters, Andrew
    Chan, Kelvin Y. K.
    Lam, Eric W. -F.
    Khoo, Ui-Soon
    PLOS ONE, 2010, 5 (08):
  • [48] Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis
    Hao Liu
    Ying Song
    Huishi Qiu
    Yanzhen Liu
    Kai Luo
    Yanmei Yi
    Guanmin Jiang
    Minying Lu
    Zhijie Zhang
    Jiang Yin
    Shanshan Zeng
    Xiangzhou Chen
    Min Deng
    Xiaoting Jia
    Yixue Gu
    Danyang Chen
    Guopei Zheng
    Zhimin He
    Cell Death & Differentiation, 2020, 27 : 966 - 983
  • [49] CCN1/ER/FOXO3a: A new connection in the hormonal response in breast cancer.
    Espinoza, Ingrid
    Liu, Hong
    Busby, Robert C.
    Lupu, Ruth
    CANCER RESEARCH, 2009, 69
  • [50] FOXO3a/FOXO1 and pPRAS40 are Prevalent in Human Breast Cancer and FOXO3a/FOXO1 and pPRAS40 Immunohistochemistry (IHC) Assays Could be Used as Pharmacodynamic Markers of AKT Pathway Activity
    Palmer, A.
    Fenton, S.
    Womack, C.
    Gray, N.
    Reiss, B.
    Bigley, G.
    Elivin, P.
    Davies, B.
    JOURNAL OF PATHOLOGY, 2012, 228 : S24 - S24
12345